Clinical analysis of human acellular allogeneic dermis in the repair of urinary fistula
10.3969/j.issn.1009-8291.2023.11.004
- VernacularTitle:脱细胞异体真皮在尿瘘修补中的临床疗效分析
- Author:
Fei LIU
1
;
Yuedong CHEN
1
;
Yankai ZENG
1
Author Information
1. Department of Urology, First Affiliated Hospital of Xiamen University, Xiamen 361003, China
- Publication Type:Journal Article
- Keywords:
human acellular allogenic dermis;
transvaginal;
repair of urinary fistula;
complex vesicovaginal fistula;
vaginal urine leakage
- From:
Journal of Modern Urology
2023;28(11):933-935
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the clinical efficacy of human acellular allogeneic dermis (HADM) in the repair of urinary fistula. 【Methods】 The clinical data of 12 female patients with complex vesicovaginal fistula treated during Jun.2021 and Nov.2022 were retrospectively analyzed. The patients’ average age was 47.3 years, ranging from 38 to 56 years. The body mass index (BMI) ranged from 16.6 to 25.2, with an average of 21.3. HADM was inserted between vagina and bladder wall fistula to repair fistula in all 12 patients. 【Results】 All operations were successful. After the operation, the vaginal urine leakage stopped and the urinary tube was retained for 2 weeks. During the postoperative follow-up of 1 to 16 months, no recurrence or complication were observed. 【Conclusion】 Transvaginal HDMA is an ideal surgical method in the treatment of complex vesicovaginal fistula, which has advantages of small trauma, fast recovery and high success rate.